Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

55.75p
   
  • Change Today:
      0.40p
  • 52 Week High: 87.40
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 965.19m
  • Volume: 892,220
  • Market Cap: £538.09m

Latest Deals

Traded Action Notifier PriceAmountValue
11-Apr-25 Transfer From Giles Wilson 0.000p 297 £0.00
11-Apr-25 Buy Giles Wilson 50.55p 297 £150.13
08-Apr-25 Buy Giles Wilson 46.92p 58 £27.21
25-Mar-25 Buy Giles Wilson 54.01p 32,640 £17,628.31
11-Mar-25 Transfer From Giles Wilson 0.000p 269 £0.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-May-24 Buy Giles Wilson 87.45p 73,145 £63,965.30
24-Sep-24 Buy Robyn Perriss 51.55p 89,054 £45,907.34
24-Sep-24 Sell Robyn Perriss 51.50p 89,054 £45,862.81
24-Sep-24 Buy Andrew Harrison 51.53p 58,220 £29,999.54
27-Aug-24 Buy Lynne Weedall 74.41p 25,000 £18,603.62

Director Shareholdings

Notifier Holding Value*
Kenny Wilson 11,513,363 £6,418,700
Paul Mason 7,875,000 £4,390,312
Giles Wilson 110,191 £61,432
Robyn Perriss 94,328 £52,588
Andrew Harrison 76,594 £42,701
Lynne Weedall 40,054 £22,330
Ian Rogers 20,270 £11,300

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £206,242,910
IngreGrsy Limited 369,942,440 £206,242,910
Permira Holdings Limited 364,142,440 £203,009,410
Artemis Investment Management LLP 86,997,521 £48,501,118
Fidelity Management & Research 32,500,000 £18,118,750
Intertrust Employee Benefit Trustee Limited 135,000 £75,262

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 55.75p
Change Today 0.40p
% Change 0.72 %
52 Week High 87.40
52 Week Low 47.52
Volume 892,220
Shares Issued 965.19m
Market Cap £538.09m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.14% above the market average57.14% above the market average57.14% above the market average57.14% above the market average57.14% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
49.81% below the market average49.81% below the market average49.81% below the market average49.81% below the market average49.81% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
56.95% above the market average56.95% above the market average56.95% above the market average56.95% above the market average56.95% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
89.04% below the market average89.04% below the market average89.04% below the market average89.04% below the market average89.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 29-Aug-24
Paid 08-Apr-25 01-Oct-24
Amount 0.85p 0.99p

Trades for 09-May-2025

Time Volume / Share Price
16:38 600 @ 55.75p
16:38 1,142 @ 55.75p
16:35 395,698 @ 55.75p
16:35 1 @ 55.75p
16:35 1,225 @ 55.75p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson
CFO Giles Wilson

Top of Page